Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Benzo(1,2-b:4,3-b')dipyrrole-1-carboxylic Acid, 8-(bromomethyl)-3,6,7,8-tetrahydro-2-methyl-4-(((4-methyl-1-piperazinyl)carbonyl)oxy)-6-((5,6,7-trimethoxy-1h-indol-2-yl)carbonyl)-, Methyl Ester, (s)-
2. Kw 2189
3. Kw-2189
4. Methyl(1s)-1-bromomethyl-7-methyl-5-((4-methylpiperazinyl)carbonyloxy)-3-((5,6,7-trimethoxy-2-indolyl)carbonyl)-1,2-dihydro-3h-pyrrolo(3,2-e)indole-8-carboxylate Hydrobromide
1. Kw-2189
2. Pibrozelesin Hbr
3. Pibrozelesin Hydrobromide [usan]
4. 148778-32-9
5. 0481jcc90t
6. Pibrozelesin Hydrobromide (usan)
7. Methyl (8s)-8-(bromomethyl)-2-methyl-4-(4-methylpiperazine-1-carbonyl)oxy-6-(5,6,7-trimethoxy-1h-indole-2-carbonyl)-7,8-dihydro-3h-pyrrolo[3,2-e]indole-1-carboxylate;hydrobromide
8. Methyl (s)-8-(bromomethyl)-3,6,7,8-tetrahydro-4-hydroxy-2-methyl-6-((5,6,7-trimethoxyindol-2-yl)carbonyl)benzo(1,2-b:4,3-b')dipyrrole-1-carboxylate, 4-methyl-1-piperazinecarboxylate (ester), Monohydrobromide
9. Unii-0481jcc90t
10. Chembl2106438
11. Pibrozelesin Hydrobromide [who-dd]
12. D05472
13. Q27247636
14. 8-(bromomethyl)-3,6,7,8-tetrahydro-2-methyl-4-(((4-methyl-1-piperazinyl)carbonyl)oxy)-6-((1,6,7-trimethoxy-1h-indol-2-yl)carbonyl)benzo(1,2-b:4,3-b')dipyrrole-1-carboxylic Acid, Methyl Ester, Monohydrobromide
15. 8-(bromomethyl)-3,6,7,8-tetrahydro-2-methyl-4-(((4-methyl-1-piperazinyl)carbonyl)oxy)-6-((1,6,7-trimethoxy-1h-indol-2-yl)carbonyl)benzo(1,2-b:4,3-b')dipyrrole-1-carboxylic Acid,-, Methyl Ester, Monohydrobromide
16. Benzo(1,2-b:4,3-b')dipyrrole-1-carboxylic Acid, 8-(bromomethyl)-3,6,7,8-tetrahydro-2-methyl-4-(((4-methyl-1-piperazinyl)carbonyl)oxy)-6-((5,6,7-trimethoxy-1h-indol-2-yl)carbonyl)-, Methyl Ester, Hydrobromide (1:1)
| Molecular Weight | 779.5 g/mol |
|---|---|
| Molecular Formula | C32H37Br2N5O8 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 9 |
| Exact Mass | 779.09884 g/mol |
| Monoisotopic Mass | 777.10089 g/mol |
| Topological Polar Surface Area | 139 Ų |
| Heavy Atom Count | 47 |
| Formal Charge | 0 |
| Complexity | 1130 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Antibiotics, Antineoplastic
Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms. (See all compounds classified as Antibiotics, Antineoplastic.)
Antineoplastic Agents, Alkylating
A class of drugs that differs from other alkylating agents used clinically in that they are monofunctional and thus unable to cross-link cellular macromolecules. Among their common properties are a requirement for metabolic activation to intermediates with antitumor efficacy and the presence in their chemical structures of N-methyl groups, that after metabolism, can covalently modify cellular DNA. The precise mechanisms by which each of these drugs acts to kill tumor cells are not completely understood. (From AMA, Drug Evaluations Annual, 1994, p2026) (See all compounds classified as Antineoplastic Agents, Alkylating.)
Antineoplastic Agents, Hormonal
Antineoplastic agents that are used to treat hormone-sensitive tumors. Hormone-sensitive tumors may be hormone-dependent, hormone-responsive, or both. A hormone-dependent tumor regresses on removal of the hormonal stimulus, by surgery or pharmacological block. Hormone-responsive tumors may regress when pharmacologic amounts of hormones are administered regardless of whether previous signs of hormone sensitivity were observed. The major hormone-responsive cancers include carcinomas of the breast, prostate, and endometrium; lymphomas; and certain leukemias. (From AMA Drug Evaluations Annual 1994, p2079) (See all compounds classified as Antineoplastic Agents, Hormonal.)
ABOUT THIS PAGE
A Chembl2106438 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Chembl2106438, including repackagers and relabelers. The FDA regulates Chembl2106438 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Chembl2106438 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Chembl2106438 supplier is an individual or a company that provides Chembl2106438 active pharmaceutical ingredient (API) or Chembl2106438 finished formulations upon request. The Chembl2106438 suppliers may include Chembl2106438 API manufacturers, exporters, distributors and traders.
click here to find a list of Chembl2106438 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Chembl2106438 DMF (Drug Master File) is a document detailing the whole manufacturing process of Chembl2106438 active pharmaceutical ingredient (API) in detail. Different forms of Chembl2106438 DMFs exist exist since differing nations have different regulations, such as Chembl2106438 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Chembl2106438 DMF submitted to regulatory agencies in the US is known as a USDMF. Chembl2106438 USDMF includes data on Chembl2106438's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Chembl2106438 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Chembl2106438 suppliers with USDMF on PharmaCompass.
Chembl2106438 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Chembl2106438 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Chembl2106438 GMP manufacturer or Chembl2106438 GMP API supplier for your needs.
A Chembl2106438 CoA (Certificate of Analysis) is a formal document that attests to Chembl2106438's compliance with Chembl2106438 specifications and serves as a tool for batch-level quality control.
Chembl2106438 CoA mostly includes findings from lab analyses of a specific batch. For each Chembl2106438 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Chembl2106438 may be tested according to a variety of international standards, such as European Pharmacopoeia (Chembl2106438 EP), Chembl2106438 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Chembl2106438 USP).
LOOKING FOR A SUPPLIER?
